info@clinicalcasereportsjournal.com

Ronald T. Ackerman

Ronald T. Ackerman

Ronald T. Ackerman

M.D., FACOG Comprehensive Clinical Research, LLC, Department of Obstetrics and Gynecology United States

BIOGRAPHY 25 PUBLICATIONS 24

We cordially invite you to join our board.

Your valuable suggestions improve our journal quality. We welcome you to be part of our board members.

Join Board
  • Ronald T. Ackerman, M.D., FACOG is Principal Investigator, Medical Director and CEO (Chief Executive Officer and Founder) for Comprehensive Clinical Research, LLC, and is Senior, Attending Physician of Advanced Women's OB/GYN.
  • Dr. Ackerman has been practicing Gynecology and Obstetrics for over 25 years. He has been conducting clinical trials since 1994  and has served as Principal Investigator in over 400 investigational research trials ranging from Phase II - IV.
  • Dr. Ackerman has authored and co-authored numerous peer-reviewed publications in medical journals.
  • Dr. Ackerman serves on many Pharmaceutical Medical Advisory Boards.
  • Dr. Ackerman also serves as a Clinical Professor at several local medical and nursing universities.
  • Dr. Ackerman was founding director of Obstetrics and Gynecology and served on the board for many years.
  • Additionally, he served as chairman of Quality Assurance. Dr. Ackerman is considered a thought leader in numerous therapeutic areas of women's healthcare by many pharmaceutical companies.

Education

  • 1974: B.A.- Hofstra University, Hempstead, New York, United States.
  • 1978: M.D. - Medical Universidad de Guadalajara, Guadalajara, Mexico.
  • 1978-1979: Fifth Pathway Program - S.U.N.Y School of Medicine at Stony Brook, New York, United States.
  • 1980-1984: Residency in OB/GYN - Long Island Jewish Medical Center, New York City, New York, United States.
  • 1983-1984: Chief Resident in OB/GYN  Long Island Jewish Medical Center, New York City, New York, United States.
  • 1987: Board Certified - American Board of Obstetrics & Gynecology, Dallas, Texas, United States.
  • 1987: Diplomat - American Board Obstetrics & Gynecology, Dallas, Texas, United States.
  • 1988: Fellow - American College Obstetrics & Gynecology, Dallas, Texas, United States.
  • 1996-present: Voluntary Re-certification - American Board of Obstetrics & Gynecology, Dallas, Texas, United States.

Clinical Training

  • 1980-1982: Resident in Obstetrics and Gynecology - Hillside Medical Center New Hyde Park, New York, United States.
  • 1983-1984: Chief Resident — Obstetrics and Gynecology - Long Island Jewish Hillside Medical Center New Hyde Park, New York, United States.
  • July 1979-July 1980: Fifth Pathway & Rotating Sub-Internship - S.U.N.Y. at Stony Brook School of Medicine, New York, United States.
  • July 1978-June 1979: New York University — New York infirmary Hospital, New York, United States.

Professional Experience

  • April 2020-Present: CEO, Principal Investigator, Medical Director, Clinical Professor - Comprehensive Clinical Research, LLC 603 Village Boulevard, Suite 301  West Palm Beach, Florida 33409, United States.
  • April 2010-Present: Founder and Senior Attending Gynecology, Obstetrics, Infertility Clinical Professor - Advanced Women's OBGYN Associates 603 Village Blvd., Suite 201 West Palm Beach, Florida 33409, United States.
  • 2001-Mar 2020: CEO, Principal Investigator, Medical Director, Clinical Professor - Comprehensive Clinical Trials, LLC  603 Village Boulevard, Suite 301 West Palm Beach, Florida 33409, United States.
  • July 1984-Mar 2010: Founder and Senior Attending Gynecology, Obstetrics, Infertility - Advanced Women's Healthcare 603 Village Boulevard, Suite 201 West Palm Beach, Florida 33409, United States.
  • 1986-March 2010: Founder and Senior Attending Gynecology, Obstetrics, Infertility - Advanced Women's Healthcare (2nd Private Practice Office} 12955 Palms West Blvd. Building 8, Suite 201 Loxahatchee, Florida 33409, United States.
  • Treatment of Endometriosis-Associated Pain with XXX, an Oral GnRH Antagonist.
  • Safety and efficacy of a novel low dose oral contraceptive regimen containing norethindrone acetate and ethinyl estradiol: results from an open-label study.
  • Performance of the XXX Xpert® TV test for the Detection of Trichomonas vaginalis in Women.
  • Efficacy of Flibansedrin in Women with Hypoactive Sexual Desire Disorder: Results from the XXX Trial.
  • American Journal of Obstetrics & Gynecology article on the Evaluation of the Accuracy of the AMPLICOR® HPV Test With the cobas x 421 Instrument (Automated Sample Preparation) and the LINEAR ARRAY HPV Genotyping Test With the cobas x 421 Instrument in Women.
  • Abstract for a phase III, double-blind, randomized, controlled, multicenter study to evaluate the efficacy of HPV-16/18   VLP/ASO4 vaccine compared to hepatitis A vaccine as control in prevention of persistent HPV-16 or HPV-18 cervical VLP/ASO4 vaccine compared to hepatitis A vaccine as control in prevention of persistent HPV-16 or HPV-18 cervical infection and cervical neoplasia, administered intramuscularly according to a 0, 1, 6 month schedule in healthy females 15-25 years of age. 15-25 years of age.
  • Presented at the North American Menopause Society 18th Annual Meeting for Estradial Gel 0.1% and its relieving properties of vasomotor symptoms independent of age, ovarian status, or uterine status.
  • Article on A Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of WC3011 (estradiol vaginal gel) in the Treatment of Symptoms of Vulvovaginal Atrophy in Postmenopausal Women, Study PR-04409.
  • Manuscript: A novel ultra-low-dose oral contraceptive: 1.0 mg norethindrone acetate and 10 pg ethinyl estradiol.
  • AUA Abstract, 5/2013: Phase III Efficacy and Safety of Once Monthly Oxybutynin Vaginal Ring Delivering 4 mg/day or 6 mg/day Versus Placebo Ring in Women with Urge Incontinence, Frequency and Urgency Symptoms of Overactive Bladder.
  • American Society of Hematology Meeting 2013: Abstract Presentation: Ferumoxytol Treatment Results in Robust Hemoglobin Increases in Iron Deficiency Anemia Patients with a History of Unsatisfactory Oral Iron Therapy in a Phase III, Randomized, Placebo-Controlled Trial.
  • Manuscript: Efficacy and Safety of a 21/7-Active Combined Oral Contraceptive with Continuous Low-Dose Etinyl Estradiol.
  • Efficacy of the HPV-16/18 ASO4 —Adjuvanted Vaccine Against Low-Risk HPV Types (Patricia Randomized Trial): An Unexpected Observation. Journal of Infectious Diseases. Vol. 208, Issue 9, pp 1391-1396. 
  • Long Term Safety of Ospemifene (52-Week Extension) in the Treatment of Vulvar and Vaginal Atrophy in Hysterectomized Postmenopausal Women. Maturitas date TBD.
  • FHR Monitoring as a Screening Test. The seventh article in the Electronic Fetal Monitoring Mythbusters series examines the value of FHR monitoring as a screening test. Contemporaryobgyn.net 11/2012 
  • Performance of the XXX Xpert® Trichomonas Rapid Test for the Detection of Trichomonas vaginalis in Male Urine Specimens. 
  • Clinical Evaluation of the XX Xpert® TV assay for the Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women .
  • Efficacy of the XXX vaccine: Pooled analysis of data from the XX vaccine and XX randomized trials.
  • Estradiol gel 0.1% relieves vasomotor symptoms independent of age, ovarian status, or uterine status.
  • Elagolix Therapy for Heavy Menstrual Bleeding in Women with Uterine Fibroids. New England Journal of Medicine 2020; 382:328-40. 
  • Clinical Validation of the XX BV and XX Candida/Trichomonas Vaginitis Assays: results from a prospective multi-center clinical study. Bacteriology.
  • Clinical evaluation of XX VeritorTM SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the XX SARS Antigen point of-care test. J. Clin. Microbiol. doi:10.1128/JCM.02338-20.
  • Efficacy, Safety, and Tolerability of a Levonorgestrel/Ethinyl Estradiol Transdermal Delivery System: Phase 3 Clinical Trial Results. Contraception.
  • Post-market clinical study of the modified BD SARS-CoV-2 Reagents for BD MAXIM system .

Are you interested in submitting your research paper?

Thank you for choosing us. We recommend you to go through our guidelines before submitting the paper.

Submit Manuscript
Logo

Clinical Case Reports Journal is the state-of-the-art platform to showcase medical journals across scientific community and a one-stop solution for publishing the manuscripts of varied medical specialities.

Main Links

Useful Links

Our Contacts

CLINICAL CASE REPORTS JOURNAL,
C/O Infact Publications LLC,
16192 Coastal Highway,
Lewes, Delaware 19958
USA

info@clinicalcasereportsjournal.com
https://clinicalcasereportsjournal.com